Lipoprotein(a) and Benefit of PCSK9 Inhibition
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
J Am Coll Cardiol 2021 Aug 03;78(5)421-433, GG Schwartz, M Szarek, VA Bittner, R Diaz, SG Goodman, JW Jukema, U Landmesser, P López-Jaramillo, G Manvelian, R Pordy, M Scemama, PR Sinnaeve, HD White, P Gabriel StegFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.